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Introduction:  
Trapped lung (TL) in mesothelioma pleural mesothelioma (MPM) is a cause of 
significant morbidity causing dyspnoea, chest pain and repeated procedures to drain 
recurrent pleural fluid necessitating multiple hospital visits/in-patient days. We aim to 
undertake a full phase III randomised controlled trial of video-assisted thoracoscopic 
partial pleurectomy/decortication (VAT-PD) versus indwelling pleural catheter (IPC) 
to determine the best method of managing trapped lung in MPM. However, prior to 
undertaking a full study there are a number of uncertainties that need to be 
addressed to inform the best design of a phase III study.  
 
i) How prevalent is trapped lung in MPM? ii) Will patients accept randomisation to 
IPC or VAT-PD? iii) What is the standard deviation of Visual Analogue Scale scores 
for dyspnoea and chest pain in each treatment group? (Required to estimate 
parameters that will be included in the sample size estimates for a phase III trial) We 
will also investigate the feasibility of undertaking a cost-effectiveness analysis from 
the perspective of the NHS. 
 
Methods:  
The primary objective is to determine the ability to randomise 1:1, 36 patients in 18 
months into a trial of VAT-PD versus IPC in patients with trapped lung and pleural 
effusion due to MPM. Data will be collected on: i) The prevalence of trapped lung in  
patients with MPM ii) Visual Analogue Scale scores for dyspnoea and chest pain and 
the patterns of change over time in each treatment group iii) Quality of Life at 
baseline, 1, 3, 6 and 12 months post randomisation iv) Collection and documentation 
of adverse events and resource use data v) Collection and documentation of 
Resource Use Data. 
 A qualitative sub-study (20 randomised patients and 10 who decline) will examine 
patient experience of the interventions and factors influencing patient decisions to 
participate and accept randomisation or not. 
 
Results:  
No results to date. 
 
Conclusion:  
The study which is funded by the NIHR Research for Patient Benefit Scheme 
opened to recruitment in the UK in July 2017.  
 
 
